• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

    5/7/25 2:00:00 PM ET
    $CNC
    $LFST
    Medical Specialities
    Health Care
    Medical/Nursing Services
    Health Care
    Get the next $CNC alert in real time by email

    Board further strengthened with appointment of Mike McFarland as Director

    National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO.

    Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO in 2022, he has led significant financial and operational transformation at the company. Previously, he spent six years as CEO of WellCare Health Plans, during which time the company delivered superb performance in both topline and profit margin expansion, resulting in exceptional value creation prior to being acquired by Centene Corporation (NYSE:CNC). He previously held senior leadership positions at United Healthcare and Cigna Corporation. Burdick brings extensive public and private board experience. He has also devoted decades of service to non-profit organizations, including United Way, Big Brothers Big Sisters and Tampa General Hospital.

    Dr. McFarland also brings substantial public company experience, including more than 40 years in the veterinary healthcare industry. For the past 11 years, he held senior leadership roles at Zoetis, Inc., including Group Director of United States Companion Animal Marketing, Executive Vice President and Group President of the Accelerated Growth Businesses, and Executive Vice President and Chief Medical Officer. Before joining Zoetis, Mike spent 15 years in emergency medicine, including five years as the Medical Director for one of the country's first and largest after-hours emergency practices. Previously, he spent 13 years at Pfizer, Inc., serving as Group Director of CAD Veterinary Operations, Group Director of U.S. Veterinary Medical Services, and Director of Specialty Hospital Services for Pfizer Animal Health. Dr. McFarland earned his Doctor of Veterinary Medicine in 1985.

    Greg Hartmann, NVA Chairman, will remain on the Board and remains invested in the company, reinforcing his enduring confidence in NVA's strategy and profitable growth opportunities.

    "It is a privilege to welcome executives of their caliber," said Hartmann. "Ken's extensive public company and multi-site clinical experience will be a tremendous asset for NVA, our care teams and the veterinary profession. Mike brings a rare combination of clinical expertise and strategic acumen, shaped by decades of leadership in animal health, that will further strengthen our Board. I am excited to work closely with Ken, Mike, the Board and the NVA leadership team as we continue NVA's journey of value creation."

    "I am honored to lead NVA as it continues on its pathway to becoming a blue-chip veterinary care company," added Burdick. "NVA's mission, culture, and commitment to compassionate clinical excellence resonate strongly with me, and I look forward to working with the Board and leadership team as we continue to build on NVA's strong foundation to create long-term value for all stakeholders."

    "Having spent my career in animal health, I've long admired NVA's focus on quality care, community, and clinical autonomy," said McFarland. "I'm pleased to join the Board and help advance NVA's continued growth and commitment to supporting veterinary teams and the pets they serve."

    About NVA

    National Veterinary Associates Group is defining the future of pet health. NVA is a community of approximately 1,300+ premier locations across North America consisting of general practice veterinary hospitals, Ethos Veterinary Health, which consists of world-class specialty and emergency hospitals, equine hospitals and pet resorts. For more information, visit http://www.nva.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250507713573/en/

    MEDIA CONTACT:

    Michelle Reardon: Michelle.reardon@nva.com

    Get the next $CNC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CNC
    $LFST

    CompanyDatePrice TargetRatingAnalyst
    Centene Corporation
    $CNC
    1/5/2026$54.00Equal Weight → Overweight
    Barclays
    LifeStance Health Group Inc.
    $LFST
    12/9/2025$8.00Overweight
    Barclays
    LifeStance Health Group Inc.
    $LFST
    11/13/2025$8.00Outperform
    BMO Capital Markets
    Centene Corporation
    $CNC
    10/14/2025$33.00Sell
    Goldman
    Centene Corporation
    $CNC
    7/28/2025$38.00Overweight → Neutral
    Cantor Fitzgerald
    LifeStance Health Group Inc.
    $LFST
    7/25/2025$8.00Buy
    BTIG Research
    Centene Corporation
    $CNC
    7/23/2025$30.00Overweight → Equal Weight
    Wells Fargo
    Centene Corporation
    $CNC
    7/21/2025$33.00Buy → Hold
    TD Cowen
    More analyst ratings

    $CNC
    $LFST
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Centene Corporation

    SCHEDULE 13G/A - CENTENE CORP (0001071739) (Subject)

    3/26/26 5:16:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    SEC Form DEFA14A filed by Centene Corporation

    DEFA14A - CENTENE CORP (0001071739) (Filer)

    3/26/26 4:28:14 PM ET
    $CNC
    Medical Specialities
    Health Care

    SEC Form DEF 14A filed by Centene Corporation

    DEF 14A - CENTENE CORP (0001071739) (Filer)

    3/26/26 4:26:33 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    $LFST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Burdick Kenneth A bought $498,294 worth of shares (114,181 units at $4.36), increasing direct ownership by 2% to 3,436,571 units (SEC Form 4)

    4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

    8/12/25 4:30:22 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Chief Executive Officer London Sarah bought $490,365 worth of shares (19,230 units at $25.50), increasing direct ownership by 2% to 845,275 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    8/11/25 5:28:22 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Samuels Theodore R. Ii bought $248,580 worth of shares (9,000 units at $27.62) (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    7/29/25 6:01:58 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    $LFST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Pardo Ryan

    4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

    4/3/26 6:49:02 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    SEC Form 4 filed by Tanji Kenneth

    4 - CENTENE CORP (0001071739) (Issuer)

    3/31/26 6:02:17 PM ET
    $CNC
    Medical Specialities
    Health Care

    SEC Form 4 filed by Samuels Theodore R. Ii

    4 - CENTENE CORP (0001071739) (Issuer)

    3/31/26 6:02:11 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    $LFST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CENTENE CORPORATION TO HOST 2026 FIRST QUARTER FINANCIAL RESULTS EARNINGS CALL

    ST. LOUIS, April 10, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, shared today that it will release its 2026 first quarter financial results at approximately 6:00 a.m. ET on Tuesday, April 28, 2026, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 (toll free) in the U.S. and Canada; +1-412-902-6506 (toll) from abroad, including the following Elite Entry Number: 0526

    4/10/26 9:48:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    LifeStance Publishes Outcomes Data Validating the Benefit of Mental Health Treatment at Scale

    Analysis of 180,000 Patients Validates Measurement-Informed Care for Anxiety and DepressionSCOTTSDALE, Ariz., April 9, 2026 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of outpatient mental health care, published new clinical outcomes data demonstrating that LifeStance patients treated for anxiety and depression broadly experienced clinically significant improvements in their symptoms. The analysis included nearly 180,000 patients who initiated care between September 2024 and December 2025 across the 33 states LifeStance serves. Key findings include:A

    4/9/26 9:00:00 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Sunshine Health Delivers Career Pathways for Floridians and Advances Healthcare Workforce

    FORT LAUDERDALE, Fla., April 7, 2026 /PRNewswire/ -- Sunshine Health, a company of Centene Corporation (NYSE:CNC), is proud to highlight the 2025 results of Sunshine Health Works, a comprehensive workforce development program designed to address critical labor shortages across Florida's healthcare system while creating clear pathways for individuals to enter, remain, and advance in healthcare careers. Since its launch, Sunshine Health Works has helped support and train nearly 1,900 people through partnerships with local colleges, healthcare providers, and community-based organiz

    4/7/26 12:02:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    $LFST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Centene upgraded by Barclays with a new price target

    Barclays upgraded Centene from Equal Weight to Overweight and set a new price target of $54.00

    1/5/26 8:29:16 AM ET
    $CNC
    Medical Specialities
    Health Care

    Barclays initiated coverage on LifeStance Health Group with a new price target

    Barclays initiated coverage of LifeStance Health Group with a rating of Overweight and set a new price target of $8.00

    12/9/25 8:50:31 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    BMO Capital Markets initiated coverage on LifeStance Health Group with a new price target

    BMO Capital Markets initiated coverage of LifeStance Health Group with a rating of Outperform and set a new price target of $8.00

    11/13/25 9:14:47 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    $CNC
    $LFST
    Leadership Updates

    Live Leadership Updates

    View All

    Centene Announces New Executive Leadership Structure

    Appoints Daniel Finke to Group President, Markets and Commercial and Wellcare CEO Michael Carson to Group President, Medicare and Specialty  ST. LOUIS, April 6, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, today announced the creation of two new executive leadership positions, which will report to Chief Executive Officer Sarah London. Centene has hired Daniel Finke as Group President, Markets and Commercial, and appointed Michael Carson to Group President, Medicare and Specialty. "We are pl

    4/6/26 7:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    Sarah Personette Appointed to LifeStance Board of Directors

    Director William Miller to Step Down SCOTTSDALE, Ariz., Aug. 22, 2025 /PRNewswire/ -- LifeStance Health (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, today announced the appointment of Sarah Personette, an accomplished customer experience, media and technology executive, to the company's board of directors, effective today. William Miller, Wellsky Chairman and CEO, will step down from the board after five years of service. "Sarah's longstanding focus on understanding consumer behavior to improve the customer experience parallels our com

    8/22/25 9:00:00 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    eHealth Announces CEO Succession

    Derrick Duke Appointed Chief Executive Officer After Transition Period Fran Soistman to Retire, Remain on eHealth Board of Directors AUSTIN, Texas, July 29, 2025 /PRNewswire/ -- eHealth, Inc. (NASDAQ:EHTH), a leading private online health insurance marketplace (the "Company"), today announced that the Company's Board of Directors has appointed Derrick Duke as its next Chief Executive Officer. Duke will join eHealth on August 4th 2025, to begin the transition process before officially stepping into the CEO role and joining the Board of Directors on September 18th, 2025. He will succeed Fran Soistman, who, as previously announced, will retire from his role as CEO while continuing to serve on t

    7/29/25 9:00:00 AM ET
    $CNC
    $EHTH
    Medical Specialities
    Health Care
    Specialty Insurers
    Finance

    $CNC
    $LFST
    Financials

    Live finance-specific insights

    View All

    CENTENE CORPORATION TO HOST 2026 FIRST QUARTER FINANCIAL RESULTS EARNINGS CALL

    ST. LOUIS, April 10, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, shared today that it will release its 2026 first quarter financial results at approximately 6:00 a.m. ET on Tuesday, April 28, 2026, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 (toll free) in the U.S. and Canada; +1-412-902-6506 (toll) from abroad, including the following Elite Entry Number: 0526

    4/10/26 9:48:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    LifeStance to Host Fourth Quarter and Full Year 2025 Earnings Conference Call on February 25, 2026

    SCOTTSDALE, Ariz., Feb. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter and full year 2025 earnings release before the market opens on Wednesday, February 25, 2026. LifeStance will host a live earnings conference call to discuss fourth quarter and full year results on February 25, 2026, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 3993891, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentat

    2/9/26 4:10:00 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    CENTENE CORPORATION REPORTS 2025 RESULTS AND ANNOUNCES 2026 GUIDANCE

    -- 2025 Full Year GAAP Diluted Loss Per Share of $(13.53); Adjusted Diluted Earnings Per Share of $2.08 -- -- 2026 Adjusted Diluted Earnings Per Share Guidance of Greater than $3.00 -- Consolidated HBR of 94.3% in the fourth quarter of 2025, which includes a Commercial HBR of 95.4% that was 100 basis points higher than expectations driven by net out of period items.Medicaid HBR of 93.0% in the fourth quarter of 2025, reflecting continued progress and representing 40 basis points of sequential improvement compared to the third quarter.Fundamental fourth quarter 2025 trend was consistent with expectations in Medicaid and Medicare Advantage, and slightly favorable in Marketplace and Medicare PD

    2/6/26 6:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    $LFST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

    SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

    11/14/24 4:34:15 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by Centene Corporation

    SC 13G - CENTENE CORP (0001071739) (Subject)

    11/14/24 4:06:01 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

    SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

    11/14/24 9:59:56 AM ET
    $LFST
    Medical/Nursing Services
    Health Care